The MRI Institute, Canada is a not-for-profit research organization specializing in the development of new research in cardiovascular, neurological, and oncological imaging. They are dedicated to the dissemination of this information to the research community and the public. Their expertise lies in susceptibility weighted imaging (SWI) and quantitative susceptibility mapping (QSM).

They invent, design, and implement MRI data acquisition sequences, image reconstruction algorithms, and post-processing software for studying neurological diseases and conditions. In the clinical domain, they collaborate with universities and radiologists worldwide to apply SWI and QSM to various applications, including stroke, traumatic brain injury (TBI), multiple sclerosis (MS), and Parkinson's disease. At the MRI Institute, Dr.

E. Mark Haacke, PhD, a renowned industry leader, serves as President & Chairman of the Board. Brian Haacke, BS, serves as the Executive Vice-President, and Dr.

Saifeng Liu, Ph. D., and Dr. Sagar Buch, Ph.

D., are experienced research scientists contributing to the institute's projects